Concepedia

David Kinsley

DK

9

Publications

723

Citations

9

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Boehringer Ingelheim (United States)

University of Pittsburgh

La Roche College

AGCO (United Kingdom)

David Kinsley is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, autoimmunity, and immunology.

Top concepts

Publications per year

2001–2020

9

Publications

9

Ectopic Expression of the Murine Chemokines CCL21a and CCL21b Induces the Formation of Lymph Node-Like Structures in Pancreas, But Not Skin, of Transgenic Mice

Shucheng Chen, Galya Vassileva, David Kinsley et al. · The Journal of Immunology · 2002 · 201 citations · Full text

, , +16

Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice

Michaela C. Stanton, Shu‐Cheng Chen, James V. Jackson et al. · Journal of Inflammation · 2011 · 134 citations · Full text

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Chung-Her Jenh, Mary Ann Cox, Long Cui et al. · BMC Immunology · 2012 · 82 citations · Full text

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

Chung‐Her Jenh, Mary Ann Cox, Long Cui et al. · BMC Immunology · 2012 · 82 citations · Full text

, , +19

MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy

Xiaohai Wang, Wenping Li, Jacob Marcus et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 73 citations · Full text

Rows per page

1–5 of 9